Immunotherapy in breast cancer: An introduction

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

Carsten Denkert, Sibylle Loibl, Aurelia Noske et al. · Journal of Clinical Oncology · 2009 · 1.8K citations

Life Sciences, Immunology, Oncology +17

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

Rita Nanda, Laura Q.M. Chow, Elizabeth Claire Dees et al. · Journal of Clinical Oncology · 2016 · 1.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

Sylvia Adams, Robert J. Gray, Sandra Demaria et al. · Journal of Clinical Oncology · 2014 · 1.3K citations · Full text

Medicine, Immunology, Oncology +17

Immune Regulation of Cancer

Mary L. Disis · Journal of Clinical Oncology · 2010 · 485 citations

Medicine, Immunology, Oncology +17

Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies

Peter Brossart, Kathrin Heinrich, Gernot Stuhler et al. · Blood · 1999 · 298 citations

Life Sciences, Immunology, Oncology +17